CSIMarket
 


Harvard Apparatus Regenerative Technology Inc   (BSTG)
Other Ticker:  
 
 

BSTG's EPS from Cont. Operations Growth by Quarter and Year

Harvard Apparatus Regenerative Technology Inc 's EPS from Cont. Operations results by quarter and year




BSTG EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.13 -0.04 -0.14
III Quarter September -0.12 -0.10 -0.09 -0.24
II Quarter June -0.19 -0.12 -0.11 -0.21
I Quarter March -0.24 -0.20 -0.07 -0.33
FY   -0.55 -0.55 -0.31 -0.92



BSTG EPS from Cont. Operations third quarter 2023 Y/Y Growth Comment
Harvard Apparatus Regenerative Technology Inc in the third quarter 2023 recorded EPS loss from Cont. Operations of $ -0.12 .

According to the results reported in the third quarter 2023, Harvard Apparatus Regenerative Technology Inc achieved the best EPS from Cont. Operations growth in Medical Equipment & Supplies industry. While Harvard Apparatus Regenerative Technology Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




BSTG EPS from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Harvard Apparatus Regenerative Technology Inc 's third quarter 2023 EPS from Cont. Operations $ -0.12 BSTG's Income Statement
Harvard Apparatus Regenerative Technology Inc 's third quarter 2022 EPS from Cont. Operations $ -0.10 Quarterly BSTG's Income Statement
New: More BSTG's historic EPS from Cont. Operations Growth >>


BSTG EPS from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Harvard Apparatus Regenerative Technology Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTG's III. Quarter Q/Q EPS from Cont. Operations Comment
Despite the fact, that Harvard Apparatus Regenerative Technology Inc in the III. Quarter 2023 showed EPS loss from Cont. Operations of $ -0.12 , management point out, that current results show slight up side relative to the -0.19 in the second quarter.

Within Medical Equipment & Supplies industry Harvard Apparatus Regenerative Technology Inc achieved highest sequential EPS from Cont. Operations growth. While Harvard Apparatus Regenerative Technology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTG's III. Quarter Q/Q EPS from Cont. Operations Comment
Although Harvard Apparatus Regenerative Technology Inc in the III. Quarter 2023 showed EPS loss from Cont. Operations of $ -0.12 , it should be said, that those numbers point to recovery relative to the -0.19 in the second quarter.

Within Medical Equipment & Supplies industry Harvard Apparatus Regenerative Technology Inc achieved highest sequential EPS from Cont. Operations growth. While Harvard Apparatus Regenerative Technology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Harvard Apparatus Regenerative Technology Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.68 $ -0.66 $ -0.59 $ -0.55 $ -0.46
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Harvard Apparatus Regenerative Technology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2023 period.
The results are getting worse as the cumulative EPS loss from Cont. Operations is inflating from $ -0.66 for the period from Jun 30 2023 to Sep 30 2022 and $ -0.45 from the TTM period ending Sep 30 2022 Akshara Verma  told.

Harvard Apparatus Regenerative Technology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Harvard Apparatus Regenerative Technology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Sep 30 2023 period.
The business is getting worse as the cumulative EPS loss from Cont. Operations is inflating from $ -0.66 for the period from Jun 30 2023 to Sep 30 2022 and $ -0.45 from the TTM period ending Sep 30 2022 Akshara Verma  mentioned.

Harvard Apparatus Regenerative Technology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Medical Equipment & Supplies Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
BSTG's EPS from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for BSTG's Competitors
EPS from Cont. Operations Growth for Harvard Apparatus Regenerative Technology Inc 's Suppliers
EPS from Cont. Operations Growth for BSTG's Customers

You may also want to know
BSTG's Annual Growth Rates BSTG's Profitability Ratios BSTG's Asset Turnover Ratio BSTG's Dividend Growth
BSTG's Roe BSTG's Valuation Ratios BSTG's Financial Strength Ratios BSTG's Dividend Payout Ratio
BSTG's Roa BSTG's Inventory Turnover Ratio BSTG's Growth Rates BSTG's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Sep 30 2023
Encompass Health Corporation34.38%$ 34.375 
West Pharmaceutical Services Inc 33.95%$ 33.951 
Lftd Partners Inc 33.33%$ 33.333 
Addus Homecare Corporation31.51%$ 31.507 
Chemed Corporation30.10%$ 30.105 
Intuitive Surgical Inc 29.67%$ 29.670 
Bristol myers Squibb Company25.33%$ 25.333 
Gilead Sciences Inc 22.38%$ 22.378 
Progyny Inc 21.43%$ 21.429 
Dexcom Inc 19.23%$ 19.231 
Envoy Medical Inc 18.18%$ 18.182 
Neurocrine Biosciences Inc 18.06%$ 18.056 
Idexx Laboratories Inc17.51%$ 17.512 
Edwards Lifesciences Corporation14.55%$ 14.545 
Zoetis Inc 14.16%$ 14.159 
Ensign Group Inc11.76%$ 11.765 
Vertex Pharmaceuticals Inc10.47%$ 10.468 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com